Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Gains from Investment Securities (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Gains from Investment Securities for 16 consecutive years, with $769000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Gains from Investment Securities rose 151.89% year-over-year to $769000.0, compared with a TTM value of $6.7 million through Jun 2025, up 389.23%, and an annual FY2025 reading of $432000.0, down 93.74% over the prior year.
  • Gains from Investment Securities was $769000.0 for Q2 2025 at Orthofix Medical, up from -$610000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $6.8 million in Q4 2024 and bottomed at -$2.8 million in Q4 2023.
  • Average Gains from Investment Securities over 5 years is $727120.8, with a median of $500000.0 recorded in 2023.
  • Peak annual rise in Gains from Investment Securities hit 624.64% in 2023, while the deepest fall reached 254.61% in 2023.
  • Year by year, Gains from Investment Securities stood at $1.4 million in 2021, then surged by 31.2% to $1.8 million in 2022, then crashed by 254.61% to -$2.8 million in 2023, then surged by 339.94% to $6.8 million in 2024, then tumbled by 88.69% to $769000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for OFIX at $769000.0 in Q2 2025, -$610000.0 in Q1 2025, and $6.8 million in Q4 2024.